alzheimer drug trials

Five younger people are believed to have developed the condition at young ages after they were given donor hormones as children to treat short stature.

A participant died in a clinical trial of a U.S. Food and Drug Administration (FDA)-approved antibody treatment for ...

Over the past two years, two Alzheimer's disease drugs were approved under accelerated approval. Both drugs are based ...

Biogen and partner Eisai Co. Ltd. are ending two late-stage trials for the experimental Alzheimer's drug aducanumab, in ...